Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
αTAT1 links microtubules to stiffness sensing, fibroblast activation, and fibrosis
Alba Santos, Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al-Hilal, Santiago Lamas, David Lagares
Alba Santos, Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al-Hilal, Santiago Lamas, David Lagares
View: Text | PDF
Research Article Cell biology Pulmonology

αTAT1 links microtubules to stiffness sensing, fibroblast activation, and fibrosis

  • Text
  • PDF
Abstract

Matrix stiffening sustains fibrosis by recruiting fibroblasts to stiff fibrotic areas through durotaxis. Once recruited, fibroblasts become mechanically activated and promote scar formation. Although actin-based mechanotransduction and focal adhesion signaling are well established, how microtubules contribute to stiffness sensing and fibroblast activation in fibrosis remains incompletely understood. Here, we identify αTAT1-mediated microtubule acetylation as a key regulator of fibroblast mechanosensing, durotaxis, and profibrotic activation. Through α-tubulin K40 acetylation, αTAT1 promotes microtubule flexibility, directional alignment, and persistent polarity along stiffness gradients, thereby enabling stiffness-directed migration and fibroblast activation. Mechanistically, αTAT1-dependent microtubule acetylation regulates focal adhesion dynamics and downstream mechanotransduction. αTAT1 loss abolishes K40 acetylation, impairs FAK-mediated YAP/TAZ signaling, and prevents stiffness- and TGF-β–induced myofibroblast differentiation. Accordingly, global or fibroblast-specific Atat1 depletion reduces fibroblast durotaxis and the accumulation of profibrotic fibroblasts, protecting mice from lung, dermal, and kidney fibrosis without affecting inflammation or vascular integrity. Our findings establish αTAT1-dependent microtubule acetylation as a conserved mechanosensing pathway that links fibroblast durotaxis and activation to fibrosis across organs in vivo, and identify αTAT1 catalytic activity as a potential mechano-therapeutic target in fibrotic disease.

Authors

Alba Santos, Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al-Hilal, Santiago Lamas, David Lagares

×

Figure 4

αTAT1 deficiency protects mice from bleomycin-induced skin fibrosis.

Options: View larger image (or click on image) Download as PowerPoint
αTAT1 deficiency protects mice from bleomycin-induced skin fibrosis.
(A)...
(A) Schematic of the mouse model of bleomycin-induced (BLM-induced) skin fibrosis. Mice received daily BLM injections for 28 days before skin harvest. (B) Representative Masson’s trichrome–stained skin sections from WT (Atat1+/+) and Atat1-deficient (Atat1–/–) mice 28 days after PBS or BLM challenge, showing reduced collagen deposition in Atat1–/– mice (n = 6 mice per group). Scale bar: 100 μm. (C) Quantification of skin collagen content by hydroxyproline assay in PBS- and BLM-treated Atat1+/+ and Atat1–/– mice (n = 6 mice per group). (D) Quantification of dermal thickness in PBS- and BLM-treated Atat1+/+ and Atat1–/– mice (n = 6 mice per group). (E) Immunofluorescence staining of skin sections showing reduced αSMA+ myofibroblast accumulation (green) in BLM-treated Atat1–/– mice compared with Atat1+/+ controls. Nuclei are stained with DAPI (blue). Scale bar: 100 μm. (F) Quantification of αSMA+ myofibroblasts per field showing reduced myofibroblast accumulation in Atat1–/– mice (n = 4 mice per group). (G) Generation of mice with conditional, fibroblast-specific Atat1 deficiency by crossing Atat1-floxed mice (INFRAFRONTIER European biorepository) with Pdgfra-CreERT2 mice (The Jackson Laboratory), which express a tamoxifen-inducible Cre recombinase in mesenchymal lineages including fibroblasts. (H) Tamoxifen administration to Pdgfra-CreERT2 Atat1fl/fl mice resulted in efficient Atat1 deletion and a marked reduction of acetylated α-tubulin in primary dermal fibroblasts, as confirmed by Western blotting. (I) Quantification of dermal thickness in fibroblast-specific Atat1-deficient mice after PBS or BLM treatment (n = 6 mice per group). (J) Quantification of skin collagen content by hydroxyproline assay in fibroblast-specific Atat1-deficient mice showing reduced collagen deposition after BLM treatment (n = 6 mice per group). For all animal experiments, data are presented as mean ± SD. Statistical significance was determined by 1-way ANOVA followed by Šidák’s multiple-comparison test. ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts